4//SEC Filing
Storgard Chris 4
Accession 0001209191-18-003921
CIK 0001434316other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:06 PM ET
Size
5.5 KB
Accession
0001209191-18-003921
Insider Transaction Report
Form 4
Storgard Chris
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-16+186,000→ 186,000 totalExercise: $6.55Exp: 2028-01-15→ Common Stock (186,000 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022.
- [F2]Not applicable.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001674703
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:06 PM ET
- Size
- 5.5 KB